Advertisement

Chemotherapy Refractory Spindle-Cell Rhabdomyosarcoma of the Bladder Treated with Consolidative Ovarian-Sparing Radical Surgery

Published:November 16, 2022DOI:https://doi.org/10.1016/j.urology.2022.10.026

      Abstract

      We present a case of chemotherapy refractory spindle cell rhabdomyosarcoma of the lower urinary tract in a 15-month-old female that ultimately required consolidative surgery with cystectomy, urethrectomy, ovarian-sparing hysterectomy, bilateral salpingectomy, anterior vaginal wall resection, and bilateral pelvic lymph node dissection. Genitourinary reconstruction was performed by ileal conduit creation and vaginoplasty. After completion of her maintenance postoperative chemotherapy regimen, the patient has remained disease-free for approximately 27 months.

      KEYWORDS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Crist W
        • Gehan EA
        • Ragab AH
        • et al.
        The Third Intergroup Rhabdomyosarcoma Study.
        J Clin Oncol. 1995; 13: 610-630
        • Crane JN
        • Xue W
        • Qumseya A
        • et al.
        Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
        Pediatr Blood Cancer. 2022; 69: e29644
        • Lautz TB
        • Martelli H
        • Fuchs J
        • et al.
        Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
        Pediatr Blood Cancer. 2020; : e28601
        • Hawkins DS
        • Chi YY
        • Anderson JR
        • et al.
        Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
        J Clin Oncol. 2018; 36: 2770-2777
        • Heyn R
        • Newton WA
        • Raney RB
        • et al.
        Preservation of the bladder in patients with rhabdomyosarcoma.
        J Clin Oncol. 1997; 15: 69-75
        • Lautz TB
        • Chi YY
        • Li M
        • et al.
        Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
        Cancer. 2021; 127: 275-283
        • Spunt SL
        • Sweeney TA
        • Hudson MM
        • Billups CA
        • Krasin MJ
        • Hester AL.
        Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors.
        J Clin Oncol. 2005; 23: 7143-7151
        • Boyd SD
        • Feinberg SM
        • Skinner DG
        • Lieskovsky G
        • Baron D
        • Richardson J.
        Quality of life survey of urinary diversion patients: comparison of ileal conduits versus continent kock ileal reservoirs.
        Journal of Urology. 1987; 138: 1386-1389
        • Imparato E
        • Alfei A
        • Aspesi G
        • Meus AL
        • Spinillo A.
        Long-term results of sigmoid vaginoplasty in a consecutive series of 62 patients.
        Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18: 1465-1469